jordi aparici market intelligence consultantn-en-marketi… · 1 jordi aparici market intelligence...
TRANSCRIPT
![Page 1: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/1.jpg)
1
JordiApariciMarketIntelligenceConsultant
Helping pharma companies make robust decisions based on market,competitors and patient knowledge
Market Intelligence | Strategy | Marketing | Market Research | DataAnalytics | Competitive Intelligence | Forecasting | Portfolio Planning |Sales Force Excellence | Business Development & Licensing | MarketAccess
![Page 2: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/2.jpg)
2
![Page 3: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/3.jpg)
3
![Page 4: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/4.jpg)
4
Preclinical Ph I Ph IIa Ph IIb PhIII Registration Price&Reimb
Launch
Market knowledge is key from the very beginningThe marketingroleinthe pipelinelifecycle
![Page 5: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/5.jpg)
5
•Brand Strategy Decisions:•Product market research (landscape, product profile test, positioning test…)•Target group•Positioning strategy•Comunication strategy
•Sales forecasting. Business case. Quantify potential patient population•Pricing and Reimbursement Strategy:
•Payer research•Price corridors
•Market Access Strategy Development•Value dossier•HTA assessment•SmPC
•Geographies: Identify key global markets•KOL network
Preclinical Ph I Ph IIa Ph IIb PhIII Registration Price&Reimb
Launch
Market knowledge is key from the very beginningThe marketingroleinthe pipelinelifecycle
![Page 6: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/6.jpg)
6
•Marketing Tactics•Identify value messages that best resonate with doctors, payers and KOLs •Master Visual Aid•Local adaptation•Key target audience•Education and disease awareness•Pricing & R. negotiation with P&R authorities•Country Market Access Strategy. Local Value dossier•Sales Force Sizing and Training
Preclinical Ph I Ph IIa Ph IIb PhIII Registration Price&Reimb
Launch
Market knowledge is key from the very beginningThe marketingroleinthe pipelinelifecycle
![Page 7: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/7.jpg)
7
• Implementación del plan táctico• Monitorizacion, market research: ATU, DFU, KPIs, posicionamiento
Preclinical Ph I Ph IIa Ph IIb PhIII Registration Price&Reimb
Launch
Market knowledge is key from the very beginningThe marketingroleinthe pipelinelifecycle
![Page 8: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/8.jpg)
8
•Market Landscape assessment•Identify treatment paradigms•Benchmark competitive market•Understand unmet needs
•Quantify Market & Opportunity Potential
•TPP, dTPP definition. Value proposition. Product positioning and indication
•Assess payers’ reactions to potential drug profile and trial design
R&D resources prioritization
Preclinical Ph I Ph IIa Ph IIb PhIII Registration Price&Reimb
Launch
Market knowledge is key from the very beginningThe marketingroleinthe pipelinelifecycle
•Assess pipeline•Steakholders
![Page 9: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/9.jpg)
9
Defining the desired productdTPP (disease targetproduct profile)
![Page 10: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/10.jpg)
1010
Defining the desired productdTPP (disease targetproduct profile)
![Page 11: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/11.jpg)
11
Characteristics Minimum (MAPP)
Target (TPP)
Competitor* (CPP)
Reference product
Indication (primary & secondary)
Target patient populationDosingFormulation & delivery mechanismEfficacy (Primary & secondary end points, QoL)
Safety & tolerability (side effects & interactions)
ContraindicationsPriceOpportunity window
Product ID: XXXX
Level of innovation: XXX
Defining the desired productTPP(targetproduct profile)
![Page 12: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/12.jpg)
12
Commercial Attractiveness
Fit w/ Company
Commercial Capabilities
R&DAttractiveness
Fit w/ Company
R&D Capabilities
Prevalence
Unmet need
Market Access
Pricing
Market and product
size
• Xxx• Xxx• Xxx• Xxx
Variables Criteria for scoreWeight
• 20%• 10%• 40%• 30%
• Xxx• Xxx• Xxx• Xxx
Dimensions
Projects Prioritization
![Page 13: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/13.jpg)
13
Prevalence
Unmet need
Market Access
Pricing
Market and product
size
Proj. X36 Proj. Y21Dimensions Proj.Y52 Proj. Z18
Commercial Attractiveness
Fit w/ Company Commercial Capabilities
R&DAttractiveness
Fit w/ CompanyR&D
Capabilities
Projects Prioritization
![Page 14: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/14.jpg)
14
Market Info Needed
©
qWhatarethetrendsinthepatientpopulation?Prevalence?Incidence?
qWhatisthediagnosisrate?Whatisthetreatmentrate?Dopatientsactivelyseektreatment?
q Isyourproducteffectiveonlyinasubpopulation?
qWhatarethepatientunmetneeds?
q Istreatmentdrivenbyspecialistsorprimarycare?Subspecialties? Hospital- oroffice-based?
q Areguidelinesinplace?
q Physicianunmetneeds
q Isthecurrenttreatmentparadigmchanging?.Whatisdoctor’sperceptiononcurrentproducts?
ModelTypeSelection,UptakeParameters,&TreatmentAssumptions
qWhataretheproductsusedtoday?Level ofuse.Placeinthelineoftherapy
q Arethereotherdevelopmentsinpipeline?Whatunmetneedaretheysolving?
qWhatdifferentiatesmy productfromthecompetition?
qWhatisthesizeofthemarket?Andproductpotential?
qWhoistheprimarypayer?Cash?PrivateInsurance?
qWhichisthepricecorridor?Aretheresignificantdiscountsandrebatesrequired?
qWillpriceaffectvolume?Anypatientco-pay?
qDoweforeseereimbursement/marketaccessrestrictions?
©
©
©
![Page 15: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/15.jpg)
15
• Primary sources:• Internet:clinicaltrials.gov,EMA,FDA,Epidemiology data• Globalsupliers:IMS,Datamonitor,Decision Resources,GlobalData,Milenium,
PipelineDatabases,etc• RealWorld Data,BigData
• Secondary sources• Market Research (quant/qual)(including Payers)• Competitive Intelligence• Congresses
• Forecasting
Methodology andSources
ü Market UnderstandingResearch
ü Product Profile Testü Patient Unmet Needs
![Page 16: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/16.jpg)
16
Prevalence
Diagnosed
Treated
Treated for the Specific Disease Segment
Patient Pool
Product X Patient Share
(at peak)
Days of Treatment
Price / Reimbursement
Sales (at peak)
Patient-based (Bottom Up)Units Sold (IMS)
Units sold (for the Specific Diagnose)
Sales-based (TopDown)
Days of Treatment
Patients TreatedMarketS
izeProd
uct
Share
Conversio
nto
Sales
Market Access burden
ForecastingSizing the potential ofthe newproduct
![Page 17: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/17.jpg)
17
Take home message:Assess the market from the very beginning so that your projects are market oriented
![Page 18: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/18.jpg)
18
![Page 19: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/19.jpg)
19
NEWPRODUCTDEVELOPMENTCreate the best product,besttecnology,best design,betterthat competitors
CUSTOMEREXPERIENCEMANAGEMENTUnderstand how she feels,discoverunmet needs,solve customer problemsandengage them
Product CentricCompany
Customer CentricCompany
Costumer CentricitySee the world asour customer does
![Page 20: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/20.jpg)
20
1.Observeand
Understand
2.Ideaand
Design
3.Implement
ation
Costumer CentricitySee the world asour customer does
![Page 21: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/21.jpg)
21
1.Observeand
Understand
2.Ideaand
Design
3.Implement
ation
![Page 22: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/22.jpg)
22
Ethnographic Market Research
![Page 23: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/23.jpg)
23
Patient JourneyTouch points identification andunderstanding
![Page 24: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/24.jpg)
24
1.Observeand
Understand
2.Ideaand
Design
3.Implement
ation
![Page 25: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/25.jpg)
25
PatientJourneyMap
• Identification of potential interventions• Selection and Prioritization• Draft design
Co-creationsessions
![Page 26: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/26.jpg)
26
1.Observeand
Understand
2.Ideaand
Design
3.Implement
ation
![Page 27: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/27.jpg)
27
• Classificationandpriorization ofinterventions• Preparetheactionplan• Cultural transformation
Customer Centricity ImplementationMindset change
![Page 28: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/28.jpg)
28
VideoAlmirall
![Page 29: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/29.jpg)
29
![Page 30: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/30.jpg)
30
• Assess the market from the very begining so that your projects are marketoriented
• See the world as your customer does• It will bring new product ideas• You will improve the interaction with customers• Customer engagement
Take HomeMessages
![Page 31: Jordi Aparici Market Intelligence Consultantn-en-Marketi… · 1 Jordi Aparici Market Intelligence Consultant Helpingpharmacompaniesmakerobustdecisionsbasedonmarket, competitorsandpatientknowledge](https://reader033.vdocuments.mx/reader033/viewer/2022060721/6081b11e6055ee08be5aa0ab/html5/thumbnails/31.jpg)
31
JordiApariciMarketIntelligenceConsultantjordi.aparici@hotmail.com
Market Intelligence | Strategy | Marketing | Market Research | DataAnalytics | Competitive Intelligence | Forecasting | Portfolio Planning |Sales Force Excellence | Business Development & Licensing | MarketAccess